Background: Adherence to tenofovir/emtricitabine (TFV/FTC)-based PrEP is critical to efficacy. The limitations of self-reported adherence in reliably capturing TFV/FTC exposure are well-known, raising interest in pharmacologic measures where drug levels are assessed in a biomatrix (e.g. plasma, peripheral blood mononuclear cells (PBMCs), dried blood spots (DBS), hair). Plasma and PBMC collection can be challenging, require refrigeration and biohazard precautions, and represent short-term exposure. Hair and DBS collection provide feasibility advantages in resource-limited settings and levels in these matrices represent longer-term exposure, although correlation between these measures is unknown. We report for the first time the correlation of drug levels and concordance of drug detection in hair and DBS in PrEP.
Methods: The iPrEX Open Label Extension (OLE) enrolled 1603 HIV-negative MSM and transwomen who previously enrolled in PrEP trials, of which 1225 initiated PrEP. DBS were collected at 4 and 8 weeks following PrEP initiation and then every 12 weeks. Hair samples were collected on an opt-in basis every 12 weeks. Hair and DBS levels of drugs were measured via liquid chromatography/ tandem mass spectrometry. Spearman’s correlation coefficients assessed relationships between TFV and FTC levels in hair and TFV-disphosphate (TFV-DP) and FTC-triphosphate (FTC-TP) concentrations in red blood cells measured with DBS.
Results: 806 paired hair-DBS samples were available for comparison in iPrEX OLE. TFV levels in hair and TFV-DP levels in DBS were strongly correlated (r 0.734, p <0.001), as were TFV in hair and FTC-TP in DBS (r 0.781, p<0.001) and FTC in hair and TFV-DP in DBS (r 0.742, p <0.001); FTC in hair and FTC-TP in DBS were more modestly correlated (r 0.587, p <0.001). A comparison of the levels of detection for the relevant antiretroviral or metabolite in the two matrices are shown in the Table. Concentrations of drugs in either matrix were mostly concordant in terms of detectability.
Conclusions: This is the first study to ever examine the correlation between concentrations of PrEP medications in hair samples and DBS, matrices in which long-term exposure to PrEP are captured. Strong correlations were observed between drug levels in hair and DBS. Further study is needed to compare the elimination kinetics and variability of TFV and FTC in hair versus TFV-DP and FTC-TP in DBS to guide the use of these measures for quantifying cumulative versus recent adherence in PrEP trials and real-world settings.